Pneumonia resulting from infection with pneumocystis jirovecii, frequently seen in the immunologically compromised, such as persons with AIDS, or steroid-treated individuals, the elderly, or premature or debilitated babies during their first three months.
Most people who get PCP have a medical condition that weakens their immune system, like HIV/AIDS, or take medicines that lower the body’s ability to fight germs and sickness. In the United States, people with HIV/AIDS are less likely to get PCP today than before the availability of antiretroviral therapy (ART). However, PCP is still a substantial public health problem. 1-3 Much of the information we have about PCP and its treatment comes from caring for patients with HIV/AIDS.
Scientists have changed both the classification and the name of this organism since it first appeared in patients with HIV in the 1980s. Pneumocystis jirovecii used to be classified as a protozoan but is now considered a fungus. 4 Pneumocystis jirovecii used to be called Pneumocystis carinii. When scientists renamed P. carinii to P. jirovecii, some people considered using the abbreviation “PJP,” but to avoid confusion, Pneumocystis jirovecii pneumonia is still abbreviated “PCP.” 5
The symptoms of PCP include:
- Difficulty breathing
- Chest pain
- Fatigue (tiredness)
PCP is extremely rare in healthy people, but the fungus that causes this disease can live in their lungs without causing symptoms. In fact, up to 20% of adults might carry this fungus at any given time, and the immune system removes the fungus after several months.
Most people who get PCP have weakened immune systems, meaning that their bodies don’t fight infections well. About 40% of people who get PCP have HIV/AIDS. 7 The other 60% of people who get PCP are usually taking medicine that lowers the body’s ability to fight germs or sickness or have other medical conditions, such as
- Solid organ transplant
- Blood cancer
- Inflammatory diseases or autoimmune diseases (for example, lupus or rheumatoid arthritis)
- Stem cell transplant
There is no vaccine to prevent PCP. A healthcare provider might prescribe medicine to prevent PCP for people who are more likely to develop the disease. The medicine most commonly used to prevent PCP is called trimethoprim/sulfamethoxazole (TMP/SMX), which is also known as co-trimoxazole and by several different brand names, including Bactrim, Septra, and Cotrim. Other medicines are available for people who cannot take TMP/SMX.
Medicine to prevent PCP is recommended for some people infected with HIV, stem cell transplant patients, and some solid organ transplant patients. 9-13 Healthcare providers might also prescribe medicine to prevent PCP in other patients, such as people who are taking long-term, high-dose corticosteroids.
PCP spreads from person to person through the air. 14-16 Some healthy adults can carry the Pneumocystis fungus in their lungs without having symptoms, and it can spread to other people, including those with weakened immune systems.
Many people are exposed to Pneumocystis as children, but they likely do not get sick because their immune systems prevent the fungus from causing an infection. In the past, scientists believed that people who had been exposed to Pneumocystis as children could later develop PCP from that childhood infection if their immune systems became weakened. However, it is more likely that people get PCP after being exposed to someone else who has PCP or who is carrying the fungus in their lungs without having symptoms.
Diagnosis and Testing
PCP is diagnosed using a sample from a patient’s lungs. The sample is usually mucus that is either coughed up by the patient (called sputum) or collected by a procedure called bronchoalveolar lavage. Sometimes, a small sample of lung tissue (a biopsy) is used to diagnose PCP. The patient’s sample is sent to a laboratory, usually to be examined under a microscope. Polymerase chain reaction (PCR) can also be used to detect Pneumocystis DNA in different types of samples.
A blood test to detect β-D-glucan (a part of the cell wall of many different types of fungi) can also help diagnose PCP.
Treatment and Outcomes
PCP must be treated with prescription medicine. Without treatment, PCP can cause death. The most common form of treatment is trimethoprim/sulfamethoxazole (TMP/SMX), which is also known as co-trimoxazole and by several different brand names, including Bactrim, Septra, and Cotrim. This medicine is given by mouth or through a vein for 3 weeks.
TMP/SMX can cause side effects such as rash and fever. Other medicines are available for patients who cannot take TMP/SMX.
Before the beginning of the HIV/AIDS epidemic in the 1980s, PCP was uncommon. In fact, clusters of PCP were one of the first signs that the HIV/AIDS epidemic was beginning in the United States. 20 PCP soon became one of the main AIDS-defining illnesses in the United States. In the late 1980s, an estimated 75% of people living with AIDS developed PCP. 21 Since then, PCP in people living with HIV/AIDS has decreased substantially due to antiretroviral therapy (ART) and preventive treatment with TMP/SMX. 2,22,23 However, PCP is still a serious health concern for people living with HIV/AIDS or other conditions that weaken the immune system. It is an opportunistic infection, which means an infection that occurs more frequently and is more severe in people with weakened immune systems. In a study of HIV-infected patients in the United States and Canada, PCP was the most common opportunistic infection during 2008–2010. 24 The exact number of cases of PCP in the United States is difficult to determine because there is no national surveillance for the disease. PCP is also a common opportunistic infection among people living with HIV/AIDS in developing countries. 25
|Wikimedia Commons has media related to Pneumocystis pneumonia.|